PedAM
Pediatric Disease Annotations & Medicines
| Disease | hyperglycemia |
| Symptom | |diabetes |
| Sentences | 382 |
| PubMedID- 23351522 | Therefore, to avoid the potential risk of ketoacidosis precipitated by olanzapine-associated hyperglycemia, persons with type i diabetes are excluded from the study. |
| PubMedID- 21912542 | Here, we detail the strategies that our institutions have employed to identify and treat hyperglycemia in patients with diabetes who present for surgery. |
| PubMedID- 22805998 | Using this model of maternal diabetes, with hyperglycemia moderated by twice daily insulin, we previously described significantly enhanced aortic contractility and endothelial dysfunction in female but not male offspring 17. we therefore sought to extend studies in this model to determine whether offspring exposed to short-term (7-day) maternal hyperglycemia in utero would display sex-specific increased blood pressure. |
| PubMedID- 24716195 | An increase of cardiovascular diseases due in part to hyperglycemia is associated with diabetes, which can induce endothelial dysfunction 2. |
| PubMedID- 23758078 | The objective of this study was to evaluate the feasibility of using telemedicine to improve glycemic control (reduce episodes of hypoglycemia and severe hyperglycemia) for residents with diabetes in a skilled nursing facility. |
| PubMedID- 24904865 | A meta-analysis of 24 studies showed that depression in patients with diabetes was significantly associated with hyperglycemia in both type 1 and type 2 diabetes mellitus24). |
| PubMedID- 25651730 | Umbilical cord mesenchymal stem cell transfusion ameliorated hyperglycemia in patients with type 2 diabetes mellitus. |
| PubMedID- 21523218 | The chronic hyperglycemia associated with diabetes leads to long-term complications including cvd, nephropathy leading to renal failure, retinopathy with potential loss of vision, and peripheral neuropathy (27). |
| PubMedID- 20334663 | Potential agents to target postprandial hyperglycemia in patients with type 2 diabetes include α-glucosidase inhibitors and glinide drugs. |
| PubMedID- 23315305 | The clinical management of hyperglycemia in patients with type 2 diabetes mellitus (t2dm) is guided not only by published treatment algorithms, but also by consideration of recent evidence and through consultation with colleagues and experts. |
| PubMedID- 22238392 | Context: dapagliflozin, a selective sodium-glucose cotransporter 2 (sglt2) inhibitor, reduces hyperglycemia in patients with type 2 diabetes mellitus (t2dm) by increasing urinary glucose excretion, and weight loss is a consistent associated finding. |
| PubMedID- 26345606 | Persistent hyperglycemia in patients with diabetes mellitus is said to be associated with various complications. |
| PubMedID- 26379785 | Chronic hyperglycemia in diabetes mellitus is known to induce numerous chronic complications including micro- and macrovascular injuries, whose diagnosis is often hampered by silent or minor clinical presentation. |
| PubMedID- 24990094 | The relationship between hyperglycemia (including diabetes) and periodontal disease (pd) has been noted previously, but its temporal sequence in the same study based on a population-based study has been barely addressed. |
| PubMedID- 21659759 | Their importance as downstream mediators of hyperglycemia in diabetes has been amply demonstrated in studies using mechanistically different inhibitors of advanced glycation to retard the development of kidney disease without directly influencing plasma glucose levels. |
| PubMedID- 23220949 | Effect of additional administration of acarbose on blood glucose fluctuations and postprandial hyperglycemia in patients with type 2 diabetes mellitus under treatment with alogliptin. |
| PubMedID- 21115767 | Type 1 diabetes leads to hyperglycemia, which is linked to a number of acute (e.g., diabetic ketoacidosis) and chronic (e.g., diabetic nephropathy and cardiovascular disease) complications (1). |
| PubMedID- 22923476 | The subsequent hyperglycemia in diabetes is the foremost risk factor for vascular complications due to enhanced rates of cellular apoptosis as observed in retinal pericytes, renal podocytes, and vascular endothelial cells (3,4). |
| PubMedID- 22135215 | hyperglycemia in diabetes causes increased oxidative stress in the vascular endothelium with generation of free radicals such as superoxide. |
| PubMedID- 24471104 | Therefore, antioxidants can prevent pathological damage caused by hyperglycemia-induced oxidative stress associated with diabetes (7). |
| PubMedID- 22529472 | it has been reported that the increasing of os during diabetes, largely due to hyperglycemia, causes neuropathy as a diabetic complication. |
| PubMedID- 24671137 | For diabetes control, poor = dm2 with hba1c≥7% and hyperglycemia, and good = dm2 with hba1c<7% and euglycemia; p values estimated by student t test for continuous variables, or chi-square for discrete variables (when cell count n>5) or fisher’s exact (when cell count n≤5); p values ≤0.099 have gray highlight and p values ≤0.05 are shown in bold; bmi, body-mass index; sd, standard deviation. |
| PubMedID- 23264428 | Unexplained hyperglycemia in a patient with type 1 diabetes may suggest impending dka, and monitoring of ketones should therefore be performed. |
| PubMedID- 22837924 | 3 our study set out to estimate the prevalence and correlates of postprandial hyperglycemia in patients with type 2 diabetes and also to identify patients with isolated postprandial hyperglycemia, who are presumed to have optimal glycemic control. |
| PubMedID- 20425570 | Although multiple drugs exist for treating the hyperglycemia associated with diabetes, few have been shown to reduce cardiovascular risk. |
| PubMedID- 24341330 | The persistent hyperglycemia in patients with type 2 diabetes mellitus is strongly associated with microvascular and macrovascular complications 1. |
| PubMedID- 23202020 | Several clinical studies have demonstrated that the long-term diabetes complications, due to hyperglycemia, and the frequency of risky short-term complications, due to hypoglycemia, could be reduced through a therapy based on a mix of diet, physical exercise, and drug delivery (including subcutaneous injections of exogenous insulin), tuned according to the monitoring of individual parameters 1. |
| PubMedID- 21074073 | The cardiovascular safety of intensive hyperglycemia treatment in patients with type 2 diabetes, particularly with certain agents, is an open debate. |
| PubMedID- 24153424 | Throughout the course of the disease, the vast majority of subjects develop symptoms of diabetes, including hyperglycemia, elevated triglycerides, low levels of high-density lipoprotein, and increase in blood pressure and waist circumference (figure 1). |
| PubMedID- 20425572 | hyperglycemia occurs in patients with diabetes and in nondiabetic patients during acute illness. |
| PubMedID- 22837722 | Metformin is a biguanide drug that is broadly used in clinical practice to prevent hyperglycemia in patients with diabetes mellitus. |
| PubMedID- 23471910 | For example, hyperglycemia in diabetes causes oxidative stress, but might also have direct effects on endothelial dysfunction. |
| PubMedID- 23199039 | Both type 1 and type 2 diabetes being associated with hyperglycemia and related disturbances in body’s metabolism can lead to serious secondary complications, such as cardiovascular disorders, nephropathy, retinopathy and neuropathy 9. |
| PubMedID- 24067431 | Dapagliflozin, a sodium-glucose cotransporter-2 inhibitor, reduces hyperglycemia in patients with diabetes and normal or mildly impaired renal function. |
| PubMedID- 24154684 | The mechanisms responsible for hyperglycemia with new onset diabetes are not clear, but are likely due to the combination of impaired insulin secretion and insulin resistance. |
| PubMedID- 22296854 | Conclusions: the present results provide first evidence indicating that ems is a new exercise method for treating postprandial hyperglycemia in individuals with type 2 diabetes, especially who cannot perform adequate voluntary exercise because of excessive obesity, orthopedic diseases, or severe diabetic complications. |
| PubMedID- 21713092 | The three major metabolic abnormalities that contribute to hyperglycemia in diabetes mellitus are defective glucose-induced insulin secretion, increased hepatic glucose output and inability of insulin to stimulate glucose uptake in the peripheral target tissues. |
| PubMedID- 22920280 | The five cases not adjudicated as diabetes included three cases of subthreshold hyperglycemia (table 3; defined in table 2), one case of diabetes with onset before t0, and one case of polycystic ovarian syndrome. |
| PubMedID- 21464945 | Insulin deficiency or resistance as well as hyperglycemia in patients with diabetes are known risk factors for metabolic bone diseases, including osteoporosis . |
| PubMedID- 21421802 | Over time, the hyperglycemia seen in patients with diabetes can increase the risk of both microvascular complications and result in a two- to fourfold increase in the risk of macrovascular complications (1–3). |
| PubMedID- 26246777 | Evidence from observational studies indicates that inpatient hyperglycemia, in patients with and without diabetes, is associated with increased risks of complications and mortality. |
| PubMedID- 24381887 | Since it often has a long asymptomatic period of hyperglycemia, many individuals with type-2 diabetes have complications at the time of diagnosis, neuropathy being most frequent. |
| PubMedID- 24355557 | Therefore, they are particularly sensitive to oxidative stress which may not only result from hyperglycemia associated with diabetes, but may also have an important causal role in β-cell failure and the development of insulin resistance and t2dm . |
| PubMedID- 22247912 | Although the kidney becomes a victim of hyperglycemia in diabetes mellitus, recent work has shown that the abnormalities of lipid and glucose metabolism in the kidney are similarly important to those in adipose tissue. |
| PubMedID- 21282368 | Recently, we have shown that serum vap-1 is elevated in acute and chronic hyperglycemia and in patients with diabetes (13). |
| PubMedID- 24076121 | hyperglycemia-induced oxidative stress leads to diabetes-associated damage to the microvasculature of the brain. |
| PubMedID- 21039714 | hyperglycemia associated with diabetes was pronounced after excision of the tumor and had been masked by the paraneoplastic effect of the tumor. |
| PubMedID- 24939606 | Chronic hyperglycemia in diabetes is associated with profound changes in lipid and lipoprotein metabolism, with resultant alterations in particle distribution within lipoprotein classes. |
| PubMedID- 24264410 | Indeed, in the setting of fully developed diabetes with frank hyperglycemia it appears more likely that this isoform should not be interfered with. |
| PubMedID- 26003073 | The patients were divided into groups based on glucose tolerance categories in the oral glucose tolerance test (impaired glucose tolerance - igt, cystic fibrosis related diabetes without fasting hyperglycemia - cfrd fh(-) or with fasting hyperglycemia - cfrd fh(+)). |